These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34400544)

  • 1. Not enough can be enough: feasibility of the Idylla
    Ercolani C; Di Benedetto A; Bonomo C; Visca P; Palange A; Assisi D; Forcella D; Terrenato I; Pescarmona E; Ciliberto G; Cecere FL; Cappuzzo F; Buglioni S
    J Clin Pathol; 2022 Dec; 75(12):844-850. PubMed ID: 34400544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Idylla
    De Luca C; Conticelli F; Leone A; Gragnano G; Salatiello M; Galasso P; Pisapia P; Grillo LR; Iaccarino A; Vigliar E; Bellevicine C; Malapelle U; Troncone G
    J Clin Pathol; 2019 Sep; 72(9):609-614. PubMed ID: 31110050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid
    Nunnari J; Graziano P; Muscarella LA; Rossi A; Grillo LR; Montrone G; Di Lorenzo A; Bronzini M; Leone A
    J Clin Pathol; 2022 May; 75(5):338-344. PubMed ID: 33597223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idylla
    Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
    J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
    De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
    J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Idylla EGFR Mutation Test for Variant Detection in Non-Small Cell Lung Cancer Samples.
    Hawkins P; Stevenson T; Powari M
    Am J Clin Pathol; 2021 Sep; 156(4):653-660. PubMed ID: 33877290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples.
    Grant J; Stanley A; Balbi K; Gerrard G; Bennett P
    J Clin Pathol; 2022 Apr; 75(4):241-249. PubMed ID: 33514586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid clinical mutational testing of
    Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
    J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla
    Michaelidou K; Karniadakis I; Pantelaion V; Koutoulaki C; Boukla E; Folinas K; Dimaras P; Papadaki MA; Koutsopoulos AV; Mavroudis D; Vourlakou C; Mavridis K; Agelaki S
    Expert Rev Mol Diagn; 2024; 24(1-2):89-98. PubMed ID: 38193169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.
    Liu CH; Chang SJ; Tsai MJ; Yang SF
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):701-706. PubMed ID: 37807651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Nakamura H; Koizumi H; Sakai H; Kimura H; Miyazawa T; Marushima H; Saji H; Takagi M
    Clin Lung Cancer; 2018 Mar; 19(2):170-174. PubMed ID: 29150249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a fast and fully automated platform to diagnose
    Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
    J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.
    Caputo A; D'Ardia A; Sabbatino F; Picariello C; Ciaparrone C; Zeppa P; D'Antonio A
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
    Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
    BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
    Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
    Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
    Chevalier LM; Billaud A; Passot C; Renoult A; Bigot F; Verrièle V; Morel A
    Ann Pathol; 2020 Sep; 40(5):389-400. PubMed ID: 32081549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
    Huang H; Springborn S; Haug K; Bartow K; Samra H; Menon S; Mackinnon AC
    J Mol Diagn; 2019 Sep; 21(5):862-872. PubMed ID: 31443844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidence.
    Szumera-Ciećkiewicz A; Olszewski WT; Tysarowski A; Kowalski DM; Głogowski M; Krzakowski M; Siedlecki JA; Wągrodzki M; Prochorec-Sobieszek M
    Int J Clin Exp Pathol; 2013; 6(12):2800-12. PubMed ID: 24294366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.